Impact of Lipoprotein(a) as Residual Risk on Long-Term Outcomes in Patients After Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Impact of Lipoprotein(a) as Residual Risk on Long-Term Outcomes in Patients After Percutaneous Coronary Intervention

Published:2015-01 Issue:2 Volume:115 Page:157-160
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Konishi Hirokazu,Miyauchi Katsumi,Kasai Takatoshi,Tsuboi Shuta,Ogita Manabu,Naito Ryo,Sai Eiryu,Fukushima Yoshifumi,Katoh Yoshiteru,Okai Iwao,Tamura Hiroshi,Okazaki Shinya,Daida Hiroyuki

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma;Steyrer;J Clin Invest,1994

2. Usefulness of Lipoprotein (a) for predicting progression of non-culprit coronary lesions after acute myocardial infarction;Ikenaga;Circ J,2011

3. Lipoprotein(a), interleukin-10, C-reactive protein, and 8-year outcome after percutaneous coronary intervention;Kardys;Clin Cardiol,2012

4. Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan–2012;Teramoto;J Atheroscler Thromb,2013

5. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between Lipoprotein(a) concentration and adverse cardiac events in patients with coronary artery disease: An observational cohort study;Indian Heart Journal;2024-05

2. Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention;Cardiovascular Diabetology;2024-03-30

3. Lipoprotein (a) as a Biomarker for Cardiovascular Diseases and Potential New Therapies to Mitigate Risk;Current Vascular Pharmacology;2023-12-20

4. Lipoprotein(a) is a new prognostic factor in patients with psoriasis and coronary artery disease: a retrospective cohort study;Lipids in Health and Disease;2023-09-02

5. Lipoprotein (a) and myocardial infarction: impact on long-term mortality;Lipids in Health and Disease;2023-06-09